Clinical trial Recruiting at 1 site Interventional Ages 4 to 10

Temporal Interference Stimulation for Children with Autism

Official title: Individualized Targeted Transcranial Temporal Interference Stimulation for Children With Autism Spectrum Disorder: A Single-Blinded, Randomized, Controlled Exploratory Trial

Run by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · NCT07625748 · Data updated 2026-11-12

This study tests whether a noninvasive brain stimulation method (tTIS) is safe and tolerable for children with autism aged 4–10.

More Autism Spectrum Disorder trials

Quick facts

Study typeInterventional
Ages4 Years to 10 Years
SexAll
Enrollment16 (estimated)
SponsorXinhua Hospital, Shanghai Jiao Tong University School of Medicine
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedMay 25, 2026
Main results expectedSeptember 30, 2026
Study endsOctober 5, 2026
Registry record updatedJune 4, 2026
Trial IDNCT07625748 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 4–10 years with a DSM-5/ADI-R/ADOS-confirmed ASD and an FSIQ of at least 50 who have parental consent.

Probably not a fit

Participants with metal implants, epilepsy, structural brain abnormalities requiring surgery, genetic syndromes, significant mental illness, severe cardiac disease, high intracranial pressure, or those in another trial or recent protocol changes may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a 5-week, single-blinded, randomized trial enrolling 16 children with autism to compare temporal interference stimulation (tTIS) against a sham control over five consecutive days. Participants in the active arm receive 1.5 mA stimulation at 2040/2000 Hz with a 40 Hz envelope for 20 minutes per session, while the sham group receives identical setup without the 40 Hz envelope. Primary outcomes focus on safety, tolerability, completion rate, and protocol adherence, with secondary outcomes including change in SRS-2 scores from baseline to end of treatment and to four weeks post-intervention. Assessments include baseline measurements, IQ testing, clinical scales, and resting-state EEG, with follow-up on symptoms, imaging, and adverse events through four weeks after completion. The study aims to determine feasibility of tTIS in pediatric ASD and to gather preliminary signals on social responsiveness changes.

Why it matters

Potential benefit: If successful, tTIS could become a feasible, noninvasive option that may help improve social responsiveness in children with ASD.

How similar studies have gone: Prior noninvasive brain stimulation approaches in pediatric ASD have shown mixed feasibility and safety signals; this study addresses feasibility and safety for tTIS in this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged 4-10 years
* Meeting the diagnostic criteria for ASD according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and confirmed by the Autism Diagnostic Observation Schedule (ADOS) and/or the Autism Diagnostic Interview-Revised (ADI-R)
* Full Scale Intelligence Quotient (FSIQ) ≥50
* Signed informed consent form

Exclusion Criteria:

* Individuals with metal implants in the body
* Individuals with neurological disorders such as epilepsy
* Those requiring surgical treatment due to structural abnormalities indicated by brain MRI examination
* Those diagnosed with genetic or chromosomal abnormalities
* Individuals with mental illness (such as early-onset schizophrenia)
* Those with severe cardiac disease
* Individuals with increased intracranial pressure
* Those currently participating in other clinical trials
* Those who received new intervention protocols within 4 weeks prior to enrollment.

Where it's running

  • Fei Li
    Shanghai, Shanghai Municipality, China
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.